FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W45894429> ?p ?o ?g. }

• W45894429 endingPage "20" @default.
• W45894429 startingPage "12" @default.
• W45894429 abstract "Abstract The Fas (Apo-1/CD95) ligand (FasL) plays a central role in the elimination of target cells by effector T lymphocytes and in the suppression of cellular immune responses against nonmalignant and malignant cells. We show the expression of FasL on the surface of neoplastic plasma cells. We provide evidence that the FasL is functionally active because five of five neoplastic plasma cell lines tested killed CEM-C7H2 T-acute lymphoblastic leukemia (T-ALL) cells. The effect was mediated via the Fas (Apo-1/CD95) receptor molecule because blocking of Fas on the target cells or the FasL on the tumor cells by receptor- and ligand-specific monoclonal antibodies (MoAbs), respectively, protected T cells from being killed by myeloma cells. In addition, overexpression of the cowpox virus protein CrmA, a molecule with inhibitory potential on caspase-1 and caspase-8, specifically involved in Fas-induced signaling, protected T cells from being destroyed by the neoplastic cells or the agonistic anti-Fas MoAb. The potential of the malignant plasma cells to extinguish target T cells was independent of their own sensitivity to the agonistic anti-Fas MoAb, and FasL-positive (FasL+) CEM-C7H2 T cells were incapable of killing myeloma cells. Our results suggest that tumor cell–induced suppression of the immune system may be exerted via the FasL active on malignant plasma cells. Furthermore, loss of Fas expression or insensitivity to the agonistic anti-Fas MoAb do not seem to be prerequisites for myeloma cells to defeat T cells via Fas/FasL interaction." @default.
• W45894429 created "2016-06-24" @default.
• W45894429 creator A5013658939 @default.
• W45894429 creator A5028662013 @default.
• W45894429 creator A5039762705 @default.
• W45894429 creator A5039994927 @default.
• W45894429 creator A5041108174 @default.
• W45894429 creator A5052617745 @default.
• W45894429 creator A5061088760 @default.
• W45894429 creator A5069887691 @default.
• W45894429 creator A5072362871 @default.
• W45894429 date "1997-07-01" @default.
• W45894429 modified "2023-10-16" @default.
• W45894429 title "Constitutive Expression of Fas (Apo-1/CD95) Ligand on Multiple Myeloma Cells: A Potential Mechanism of Tumor-Induced Suppression of Immune Surveillance" @default.
• W45894429 cites W1517945724 @default.
• W45894429 cites W1543457854 @default.
• W45894429 cites W1546319410 @default.
• W45894429 cites W1558473055 @default.
• W45894429 cites W1592205925 @default.
• W45894429 cites W1615239198 @default.
• W45894429 cites W1821146811 @default.
• W45894429 cites W1964977785 @default.
• W45894429 cites W1973792489 @default.
• W45894429 cites W1977499961 @default.
• W45894429 cites W1978018492 @default.
• W45894429 cites W1986785442 @default.
• W45894429 cites W1991109602 @default.
• W45894429 cites W1993336052 @default.
• W45894429 cites W2007689766 @default.
• W45894429 cites W2016198585 @default.
• W45894429 cites W2021126994 @default.
• W45894429 cites W2021325782 @default.
• W45894429 cites W2023602713 @default.
• W45894429 cites W2023809975 @default.
• W45894429 cites W2024801650 @default.
• W45894429 cites W2041466047 @default.
• W45894429 cites W2045796964 @default.
• W45894429 cites W2052853635 @default.
• W45894429 cites W2060820237 @default.
• W45894429 cites W2075809552 @default.
• W45894429 cites W2076229621 @default.
• W45894429 cites W2083363077 @default.
• W45894429 cites W2085583663 @default.
• W45894429 cites W2087562882 @default.
• W45894429 cites W2094334993 @default.
• W45894429 cites W2095688897 @default.
• W45894429 cites W2107947268 @default.
• W45894429 cites W2116172091 @default.
• W45894429 cites W2127993518 @default.
• W45894429 cites W2129971278 @default.
• W45894429 cites W2143996326 @default.
• W45894429 cites W2164802863 @default.
• W45894429 cites W2168747001 @default.
• W45894429 doi "https://doi.org/10.1182/blood.v90.1.12" @default.
• W45894429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9207432" @default.
• W45894429 hasPublicationYear "1997" @default.
• W45894429 type Work @default.
• W45894429 sameAs 45894429 @default.
• W45894429 citedByCount "121" @default.
• W45894429 countsByYear W458944292012 @default.
• W45894429 countsByYear W458944292013 @default.
• W45894429 countsByYear W458944292014 @default.
• W45894429 countsByYear W458944292015 @default.
• W45894429 countsByYear W458944292016 @default.
• W45894429 countsByYear W458944292017 @default.
• W45894429 countsByYear W458944292018 @default.
• W45894429 countsByYear W458944292019 @default.
• W45894429 countsByYear W458944292022 @default.
• W45894429 crossrefType "journal-article" @default.
• W45894429 hasAuthorship W45894429A5013658939 @default.
• W45894429 hasAuthorship W45894429A5028662013 @default.
• W45894429 hasAuthorship W45894429A5039762705 @default.
• W45894429 hasAuthorship W45894429A5039994927 @default.
• W45894429 hasAuthorship W45894429A5041108174 @default.
• W45894429 hasAuthorship W45894429A5052617745 @default.
• W45894429 hasAuthorship W45894429A5061088760 @default.
• W45894429 hasAuthorship W45894429A5069887691 @default.
• W45894429 hasAuthorship W45894429A5072362871 @default.
• W45894429 hasBestOaLocation W458944291 @default.
• W45894429 hasConcept C153911025 @default.
• W45894429 hasConcept C190283241 @default.
• W45894429 hasConcept C203014093 @default.
• W45894429 hasConcept C3031857 @default.
• W45894429 hasConcept C31573885 @default.
• W45894429 hasConcept C502942594 @default.
• W45894429 hasConcept C55493867 @default.
• W45894429 hasConcept C66008609 @default.
• W45894429 hasConcept C86803240 @default.
• W45894429 hasConcept C8891405 @default.
• W45894429 hasConceptScore W45894429C153911025 @default.
• W45894429 hasConceptScore W45894429C190283241 @default.
• W45894429 hasConceptScore W45894429C203014093 @default.
• W45894429 hasConceptScore W45894429C3031857 @default.
• W45894429 hasConceptScore W45894429C31573885 @default.
• W45894429 hasConceptScore W45894429C502942594 @default.
• W45894429 hasConceptScore W45894429C55493867 @default.
• W45894429 hasConceptScore W45894429C66008609 @default.
• W45894429 hasConceptScore W45894429C86803240 @default.

• next